Thu, 08th Oct 2020 11:06
BRUSSELS, Oct 8 (Reuters) - The European Commission said on
Thursday it had sealed a supply deal with Johnson & Johnson
for the supply of its potential COVID-19 vaccine for up
to 400 million people.
This is the third advance purchase contract signed by the EU
with makers of COVID-19 vaccines after deals with AstraZeneca
and Sanofi.
(Reporting by Francesco Guarascio; editing by Jason Neely
@fraguarascio)
(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of Engla...
FTSE 100 up 0.5%, FTSE 250 adds 0.4% *
(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the...
(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:
Astrazeneca (AZN)